Médica Sur, S.A.B. de C.V. (BMV:MEDICA.B)
54.00
0.00 (0.00%)
Nov 13, 2026, 2:44 PM CST
Médica Sur Income Statement
Financials in millions MXN. Fiscal year is January - December.
Millions MXN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue | 4,742 | 4,789 | 4,403 | 4,130 | 3,868 | 3,812 |
Revenue Growth | 0.93% | 8.77% | 6.61% | 6.77% | 1.46% | 21.31% |
Cost of Revenue | 3,154 | 3,135 | 2,973 | 2,727 | 2,542 | 2,347 |
Gross Profit | 1,588 | 1,654 | 1,430 | 1,403 | 1,326 | 1,466 |
Selling, General & Admin | 855.74 | 873.38 | 795.48 | 812.09 | 751.01 | 719.01 |
Other Operating Expenses | -19.52 | -21.24 | 152.76 | -32.85 | -1.83 | 12.12 |
Operating Expenses | 836.22 | 852.14 | 948.25 | 779.24 | 749.18 | 731.13 |
Operating Income | 751.49 | 801.69 | 481.76 | 623.89 | 576.76 | 734.56 |
Interest Expense | -105.13 | -106.2 | -75.58 | -75.38 | -75.95 | -76.83 |
Interest & Investment Income | 107 | 123.84 | 78.82 | 100.31 | 181.83 | 53.84 |
Currency Exchange Gain (Loss) | -1.17 | -18.4 | 22.73 | -10.88 | -2.73 | 3.1 |
EBT Excluding Unusual Items | 752.19 | 800.93 | 507.73 | 637.95 | 679.91 | 714.68 |
Impairment of Goodwill | - | - | - | - | - | -100.58 |
Gain (Loss) on Sale of Assets | -0.05 | -0.05 | -0.27 | 103.56 | -3.49 | - |
Asset Writedown | - | - | - | - | - | -0.64 |
Other Unusual Items | - | - | 86.24 | - | - | - |
Pretax Income | 752.9 | 801.64 | 594.15 | 741.51 | 677.58 | 613.46 |
Income Tax Expense | 243.65 | 261.39 | 171.68 | 183.61 | 204.79 | 255.88 |
Earnings From Continuing Operations | 509.24 | 540.25 | 422.47 | 557.9 | 472.79 | 357.58 |
Earnings From Discontinued Operations | - | - | 39.03 | 77.09 | 477.01 | 796.91 |
Net Income to Company | 509.24 | 540.25 | 461.51 | 634.98 | 949.8 | 1,154 |
Minority Interest in Earnings | -0 | -0 | -0 | -0 | -0 | 0.03 |
Net Income | 509.24 | 540.25 | 461.51 | 634.98 | 949.8 | 1,155 |
Net Income to Common | 509.24 | 540.25 | 461.51 | 634.98 | 949.8 | 1,155 |
Net Income Growth | -5.12% | 17.06% | -27.32% | -33.15% | -17.73% | 106.60% |
Shares Outstanding (Basic) | 108 | 108 | 108 | 108 | 108 | 123 |
Shares Outstanding (Diluted) | 108 | 108 | 108 | 108 | 108 | 123 |
Shares Change | -1.89% | - | - | - | -12.45% | - |
EPS (Basic) | 4.70 | 5.01 | 4.28 | 5.88 | 8.80 | 9.36 |
EPS (Diluted) | 4.70 | 5.01 | 4.28 | 5.88 | 8.80 | 9.36 |
EPS Growth | -3.29% | 17.06% | -27.32% | -33.15% | -6.04% | 106.60% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 449.77 | 802.78 | 525.77 | 215.54 | 75.76 | 670.15 |
Free Cash Flow Per Share | 4.15 | 7.44 | 4.87 | 2.00 | 0.70 | 5.44 |
Dividend Per Share | 1.600 | 1.600 | 1.500 | 1.500 | 33.363 | 2.210 |
Dividend Growth | 6.67% | 6.67% | 0% | -95.50% | 1409.64% | 47.33% |
Gross Margin | 33.48% | 34.53% | 32.48% | 33.98% | 34.28% | 38.45% |
Operating Margin | 15.85% | 16.74% | 10.94% | 15.11% | 14.91% | 19.27% |
Profit Margin | 10.74% | 11.28% | 10.48% | 15.38% | 24.56% | 30.29% |
Free Cash Flow Margin | 9.49% | 16.76% | 11.94% | 5.22% | 1.96% | 17.58% |
EBITDA | 922.19 | 982.93 | 657.64 | 785.49 | 723.5 | 810.51 |
EBITDA Margin | 19.45% | 20.52% | 14.94% | 19.02% | 18.70% | 21.26% |
D&A For EBITDA | 170.7 | 181.25 | 175.88 | 161.6 | 146.74 | 75.95 |
EBIT | 751.49 | 801.69 | 481.76 | 623.89 | 576.76 | 734.56 |
EBIT Margin | 15.85% | 16.74% | 10.94% | 15.11% | 14.91% | 19.27% |
Effective Tax Rate | 32.36% | 32.61% | 28.89% | 24.76% | 30.22% | 41.71% |
Advertising Expenses | - | 30.02 | 32 | 30.62 | 34.71 | 32.09 |